Assessment of Glypican 3 as Apredictive Marker in Colorectal Cancer Patients
Condition(s):Colorectal CancerLast Updated:January 13, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Colorectal CancerLast Updated:January 13, 2022Not yet recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:February 24, 2022Completed
Condition(s):Hepatocellular CarcinomaLast Updated:September 13, 2023Recruiting
Condition(s):Advanced Hepatocellular CarcinomaLast Updated:January 31, 2023Completed
Condition(s):Hepatocellular CarcinomaLast Updated:February 6, 2023Completed
Condition(s):Liver CancerLast Updated:June 6, 2023Active, not recruiting
Condition(s):Hepatocellular Carcinoma; HepatoblastomaLast Updated:May 20, 2020Withdrawn
Condition(s):Liver Cancer; Rhabdomyosarcoma; Malignant Rhabdoid Tumor; Liposarcoma; Wilms Tumor; Yolk Sac TumorLast Updated:July 7, 2023Recruiting
Condition(s):Liver Cell Carcinoma; Solid Tumor; Wilms Tumor; Malignant Rhabdoid Tumor; Yolk Sac Tumor; Rhabdomyosarcoma; Liposarcoma; Embryonal Sarcoma of the LiverLast Updated:August 23, 2023Recruiting
Condition(s):Liver Cancer; Rhabdomyosarcoma; Malignant Rhabdoid Tumor; Liposarcoma; Wilms Tumor; Yolk Sac TumorLast Updated:February 5, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.